A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Elderly Adults

Clinical trial NCT04822025 · COMPLETED

Trial details

NCT number: NCT04822025
Sponsor: Medigen Vaccine Biologics Corp.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Covid19 Vaccine

Start date: 2021-05-20
Primary completion: 2021-08-25
Enrollment: 420

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.